|Bid||46.75 x 600|
|Ask||46.78 x 1000|
|Day's Range||46.31 - 46.58|
|52 Week Range||38.05 - 50.22|
|PE Ratio (TTM)||19.85|
|Dividend & Yield||0.51 (1.12%)|
|1y Target Est||51.00|
LONDON, UK / ACCESSWIRE / August 9, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Fresenius Medical Care AG & Co. KGAA (NYSE: FMS ), following which ...
Fresenius’s minority-owned kidney dialysis business agreed to acquire NxStage Medical Inc. for about $2 billion.
The pending acquisition by Fresenius put NxStage's second-quarter financial report in a much different context.